Myoglobin induces oxidative stress and decreases endocytosis and monolayer permissiveness in cultured kidney epithelial cells without affecting viability

Kidney and Blood Pressure Research

Volumn 31, Issue 1, 2008, Pages 16-28

  Parry, Sarah N ^a   Ellis, Natasha ^a   Li, Zhe ^a   Maitz, Peter ^a   Witting, Paul K ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Antioxidant gene regulation; Burns; Endocytosis; Myoglobinuria; Oxidative stress

Indexed keywords

CATALASE; CLATHRIN; GLUTATHIONE; HEME OXYGENASE 1; INULIN; LIPOCORTIN 5; MYOGLOBIN; PROPIDIUM IODIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; ENDOCYTOSIS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE CONTROL; GENE EXPRESSION; IMMUNOFLUORESCENCE; KIDNEY CELL; KIDNEY EPITHELIUM; MITOCHONDRION; NECROSIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DOGS; ENDOCYTOSIS; EPITHELIAL CELLS; KIDNEY; MYOGLOBIN; OXIDATIVE STRESS;

EID: 39749115852     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112921     Document Type: Article

References (62)

1. Kim GH, Oh KH, Yoon JW, Koo JW, Kim HJ, Chae DW, Noh JW, Kim JH, Park YK: Impact of burn size and initial serum albumin level on acute renal failure occurring in major burn. Am J Nephrol 2003;23:55-60.
2. Schiavon M, Di Landro D, Baldo M, De Silvestro G, Chiarelli A: A study of renal damage in seriously burned patients. Burns Incl Therm Inj 1988;14:107-112.
3. Holm C, Horbrand F, von Donnersmarck GH, Muhlbauer W: Acute renal failure in severely burned patients. Burns 1999;25:171-178.
4. Davies DM, Pusey CD, Rainford DJ, Brown JM, Bennett JP: Acute renal failure in burns. Scand J Plast Reconstr Surg 1979;13:189-192.
5. Vertel R, Knochel JP: Nonoliguric acute renal failure. JAMA 1969;200:598-603.
6. Swanson CR, Chamelin NC, Territo L (eds): Criminal Investigation, ed 7. Melbourne, McGraw-Hill, 2003.
7. Aikawa N, Wakabayashi G, Ueda M, Shinozawa Y: Regulation of renal function in thermal injury. J Trauma 1990;30:S174-S178.
8. Tremblay R, Ethier J, Querin S, Beroniade V, Falardeau P, Leblanc M: Veno-venous continuous renal replacement therapy for burned patients with acute renal failure. Burns 2000;26:638-643.
9. Chrysopoulo MT, Jeschke MG, Dziewulski P, Barrow RE, Herndon DN: Acute renal dysfunction in severely burned adults. J Trauma 1999;46:141-144.
10. Vetterlein F, Hoffmann F, Pedina J, Neckel M, Schmidt G: Disturbances in renal microcirculation induced by myoglobin and hemorrhagic hypotension in anesthetized rat. Am J Physiol 1995;268:F839-F846.
11. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314-326.
12. Lieberthal W, Levine JS: Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 1996;271:F477-F488.
13. Rayner BS, Wu BJ, Raftery M, Stocker R, Witting PK: Human S-nitroso oxymyoglobin is a store of vasoactive nitric oxide. J Biol Chem 2005;280:9985-9993.
14. Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, Roberts LJ 2nd: A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998;273:31731-31737.
15. Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care 2005;9:R90-R95.
16. Reeder BJ, Svistunenko DA, Sharpe MA, Wilson MT: Characteristics and mechanism of formation of peroxide-induced heme to protein cross-linking in myoglobin. Biochemistry 2002;41:367-375.
17. Reeder BJ, Sharpe MA, Kay AD, Kerr M, Moore K, Wilson MT: Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem Soc Trans 2002;30:745-748.
18. 2. Involvement of a thiyl radical produced at cysteine 110. J Biol Chem 2000;275:20391-20398.
19. 2. Electron transfer between tyrosine 103 phenoxyl radical and cysteine 110 yields a protein-thiyl radical. J Biol Chem 2001;276:16540-16547.
20. Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ 2nd, Moore K: Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 1999;353:1241.
21. Reeder BJ, Svistunenko DA, Cooper CE, Wilson MT: The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid Redox Signal 2004;6:954-966.
22. Zager RA, Foerder C, Bredl C: The influence of mannitol on myoglobinuric acute renal failure: functional, biochemical, and morphological assessments. J Am Soc Nephrol 1991;2:848-855.
23. Zhu BL, Ishida K, Quan L, Taniguchi M, Oritani S, Kamikodai Y, Fujita MQ, Maeda H: Post-mortem urinary myoglobin levels with reference to the causes of death. Forensic Sci Int 2001;115:183-188.
24. Rayner BS, Duong TT, Myers SJ, Witting PK: Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J Neurochem 2006;97:211-221.
25. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, Van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420.
26. Sattler W, Mohr D, Stocker R: Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence: Methods Enzymol 1994;233:469-489.
27. Ahmed H, Schott EJ, Gauthier JD, Vasta GR: Superoxide dismutases from the oyster parasite Perkinsus marinus : purification, biochemical characterization, and development of a plate microassay for activity. Anal Biochem 2003;318:132-141.
28. Cao Z, Li Y: Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 2004;489:39-48.
29. Apodaca G, Bomsel M, Lindstedt R, Engel J, Frank D, Mostov KE, Wiener-Kronish J: Characterization of Pseudomonas aeruginosa -induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun 1995;63:1541-1551.
30. Tanner FC, Greutert H, Barandier C, Frischknecht K, Luscher TF: Different cell cycle regulation of vascular smooth muscle in genetic hypertension. Hypertension 2003;42:184-188.
31. Weber T, Dalen H, Andera L, Negre-Salvayre A, Auge N, Sticha M, Lloret A, Terman A, Witting PK, Higuchi M, Plasilova M, Zivny J, Gellert N, Weber C, Neuzil J: Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 2003;42:4277-4291.
32. Hack B, Witting PK, Rayner BS, Stocker R, Headrick JP: Oxidant stress and damage in post-ischemic mouse hearts: effects of adenosine. Mol Cell Biochem 2006;287:165-175.
33. Galaris D, Cadenas E, Hochstein P: Glutathione-dependent reduction of peroxides during ferryl- and met-myoglobin interconversion: a potential protective mechanism in muscle. Free Radic Biol Med 1989;6:473-478.
34. Von Bonsdorff CH, Fuller SD, Simons K: Apical and basolateral endocytosis in Madin-Darby canine kidney (MDCK) cells grown on nitrocellulose filters. EMBO J 1985;4:2781-2792.
35. Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DW: Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun 1999;67:6670-6677.
36. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-135.
37. Kormoczi GF, Saemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, Dunkler D, Spitzauer S, Panzer S: Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006;36:202-209.
38. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (eds): Molecular Biology of the Cell. New York, Garland Publishing, 1994.
39. Maratos-Flier E, Kao CY, Verdin EM, King GL: Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J Cell Biol 1987;105:1595-1601.
40. Mostov KE, Simister NE: Transcytosis. Cell 1985;43:389-390.
41. Bomsel M, Prydz K, Parton RG, Gruenberg J, Simons K: Endocytosis in filter-grown Madin-Darby canine kidney cells. J Cell Biol 1989;109:3243-3258.
42. Halliwell B: Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999;31:261-272.
43. Tyrrell R: Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 1999;31:335-340.
44. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.
45. Malorni W, Testa U, Rainaldi G, Tritarelli E, Peschle C: Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. Exp Cell Res 1998;241:102-116.
46. Yin W, Jiang G, Takeyasu K, Zhou X: Stimulation of Na,K-ATPase by low potassium is dependent on transferrin. J Membr Biol. 2003;193:177-184.
47. Hishida A, Kato A, Yamada M: Myoglobinuria and acute renal failure. Rinsho Byori 1991;39:110-114.
48. Cereijido M, Valdes J, Shoshani L, Contreras RG: Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998;60:161-177.
49. Sakata S, Yoshioka N, Atassi MZ: Human haptoglobin binds to human myoglobin. Biochim Biophys Acta 1986;873:312-315.
50. Sadrzadeh SM, Bozorgmehr J: Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004;121:S97-S104.
51. Zvi B, Levy AP: Haptoglobin phenotypes, which one is better and when? Clin Lab 2006;52:29-35.
52. Awadallah S, Hamad M: A study of haptoglobin phenotypes in patients with chronic renal failure. Ann Clin Biochem 2003;40:680-683.
53. Fagoonee S, Gburek J, Hirsch E, Marro S, Moestrup SK, Laurberg JM, Christensen EI, Silengo L, Altruda F, Tolosano E: Plasma protein haptoglobin modulates renal iron loading. Am J Pathol 2005;166:973-983.
54. Burbea Z, Nakhoul F, Rosenberg S, Zoabi R, Skorecki K, Hochberg I, Miller-Lotan R, Benchetrit S, Weissgarten J, Knecht A, Tovbin D, Levy NS, Levy AP: Role of haptoglobin phenotype in end-stage kidney disease. Nephron Exp Nephrol 2004;97:e71-e76.
55. Lim YK, Jenner A, Ali AB, Wang Y, Hsu SI, Chong SM, Baumman H, Halliwell B, Lim SK: Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int 2000;58:1033-1044.
56. 103 affects rate and product distribution. Biochem J 2004;381:365-372.
57. Minigh JL, Valentovic MA: Characterization of myoglobin toxicity in renal cortical slices from Fischer 344 rats. Toxicology 2003;187:77-87.
58. Zager RA, Foerder CA: Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest 1992;89:989-995.
59. 2 and myoglobin-induced proximal tubular cell attack. Kidney Int 1998;53:1661-1672.
60. Puschel K, Lockemann U, Bartel J: Postmortem investigation of serum myoglobin levels with special reference to electrical fatalities. Forensic Sci Int 1995;72:171-177.
61. Kormoczi GF, Saemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, Dunkler D, Spitzauer S, Panzer S: Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006;36:202-209.
62. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK: Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.